A kinesin signaling complex mediates the ability of GSK-3β to affect mood-associated behaviors

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 25, 2010, Pages 11573-11578

  Du, Jing ^a   Wei, Yanling ^a   Liu, Lidong ^b   Wang, Yun ^a   Khairova, Rushaniya ^a   Blumenthal, Rayah ^a   Tragon, Tyson ^a   Hunsberger, Joshua G ^a   Machado Vieira, Rodrigo ^a   Drevets, Wayne ^a   Wang, Yu Tian ^b   Manji, Husseini K ^c  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c JOHNSON AND JOHNSON   (United States)

Author keywords

amino 3 hydroxyl 5 methyl 4 isoxazole propionate receptor; Internalization; Kinesin light chain 2

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; ANTIDEPRESSANT AGENT; ARA 014418; ENZYME INHIBITOR; GLYCOGEN SYNTHASE KINASE 3 INHIBITOR; GLYCOGEN SYNTHASE KINASE 3BETA; KINESIN; N METHYL DEXTRO ASPARTIC ACID; TAT CON PEPTIDE; TAT KLC PEPTIDE; TAT KLCPCDK PEPTIDE; UNCLASSIFIED DRUG; AMPA RECEPTOR; DRUG DERIVATIVE; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; KINESIN LIGHT CHAIN PROTEINS; KINESIN LIGHT-CHAIN PROTEINS; LITHIUM; MICROTUBULE ASSOCIATED PROTEIN; N (4 METHOXYBENZYL) N' (5 NITRO 1,3 THIAZOL 2 YL)UREA; N-(4-METHOXYBENZYL)-N'-(5-NITRO-1,3-THIAZOL-2-YL)UREA; THIAZOLE DERIVATIVE; UREA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG MECHANISM; DRUG TARGETING; LOCOMOTION; MALE; MOOD DISORDER; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; AFFECT; ANIMAL; BIOLOGICAL MODEL; BIPOLAR DISORDER; DRUG EFFECT; HIPPOCAMPUS; METABOLISM; MOUSE; SYNAPSE;

ANIMALIA;

AFFECT; ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; ANIMALS; ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; GLYCOGEN SYNTHASE KINASE 3; HIPPOCAMPUS; KINESIN; LITHIUM; MALE; MICE; MICROTUBULE-ASSOCIATED PROTEINS; MODELS, BIOLOGICAL; NEURONAL PLASTICITY; RECEPTORS, AMPA; SYNAPSES; THIAZOLES; UREA;

EID: 77954904485     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0913138107     Document Type: Article

References (38)

1. Goodwin GM, Geddes JR (2003) Latest maintenance data on lithium in bipolar disorder. Eur Neuropsychopharmacol 13 (Suppl 2):S51-S55. (Pubitemid 37083233)
2. Klein PS, Melton DA (1996) A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci USA 93:8455-8459.
3. Serretti A, et al. (2008) Association between GSK-3β-50T/C polymorphism and personality and psychotic symptoms in mood disorders. Psychiatry Res 158:132-140. (Pubitemid 351291662)
4. Grimes CA, Jope RS (2001) The multifaceted roles of glycogen synthase kinase 3β in cellular signaling. Prog Neurobiol 65:391-426.
5. Gould TD, Einat H, Bhat R, Manji HK (2004) AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test. Int J Neuropsychopharmacol 7:387-390. (Pubitemid 39648068)
6. O'Brien WT, et al. (2004) Glycogen synthase kinase-3β haploinsufficiency mimics the behavioral and molecular effects of lithium. J Neurosci 24:6791-6798.
7. Du J, et al. (2008) The role of hippocampal GluR1 and GluR2 receptors in manic-like behavior. J Neurosci 28:68-79.
8. Du J, et al. (2007) The anticonvulsants lamotrigine, riluzole, and valproate differentially regulate AMPA receptor membrane localization: Relationship to clinical effects in mood disorders. Neuropsychopharmacology 32:793-802. (Pubitemid 46426179)
9. Hu H, et al. (2007) Emotion enhances learning via norepinephrine regulation of AMPA-receptor trafficking. Cell 131:160-173.
10. Li X, et al. (2001) Antidepressant-like actions of an AMPA receptor potentiator (LY392098). Neuropharmacology 40:1028-1033.
11. Peineau S, et al. (2007) LTP inhibits LTD in the hippocampus via regulation of GSK3β. Neuron 53:703-717.
12. Wodarz A, Nusse R (1998) Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Biol 14:59-88.
13. Man HY, et al. (2000) Regulation of AMPA receptor-mediated synaptic transmission by clathrin-dependent receptor internalization. Neuron 25:649-662.
14. Setou M, et al. (2002) Glutamate-receptor-interacting protein GRIP1 directly steers kinesin to dendrites. Nature 417:83-87.
15. Sun X, Zhao Y, Wolf ME (2005) Dopamine receptor stimulation modulates AMPA receptor synaptic insertion in prefrontal cortex neurons. J Neurosci 25:7342-7351.
16. Beattie EC, et al. (2000) Regulation of AMPA receptor endocytosis by a signaling mechanism shared with LTD. Nat Neurosci 3:1291-1300.
17. Lee HK, Barbarosie M, Kameyama K, Bear MF, Huganir RL (2000) Regulation of distinct AMPA receptor phosphorylation sites during bidirectional synaptic plasticity. Nature 405:955-959.
18. Shi SH, et al. (1999) Rapid spine delivery and redistribution of AMPA receptors after synaptic NMDA receptor activation. Science 284:1811-1816.
19. Beaulieu JM, Gainetdinov RR, Caron MG (2009) Akt/GSK3 signaling in the action of psychotropic drugs. Annu Rev Pharmacol Toxicol 49:327-347.
20. Kannoji A, Phukan S, Sudher Babu V, Balaji VN (2008) GSK3β: A master switch and a promising target. Expert Opin Ther Targets 12:1443-1455.
21. Kessels HW, Malinow R (2009) Synaptic AMPA receptor plasticity and behavior. Neuron 61:340-350.
22. Carlezon WA, Jr, Nestler EJ (2002) Elevated levels of GluR1 in the midbrain: A trigger for sensitization to drugs of abuse? Trends Neurosci 25:610-615.
23. Karcher RL, Deacon SW, Gelfand VI (2002) Motor-cargo interactions: The key to transport specificity. Trends Cell Biol 12:21-27.
24. Mizuno N, et al. (2004) Dynein and kinesin share an overlapping microtubule-binding site. EMBO J 23:2459-2467.
25. Carroll RC, et al. (1999) Dynamin-dependent endocytosis of ionotropic glutamate receptors. Proc Natl Acad Sci USA 96:14112-14117.
26. Jaskolski F, Mayo-Martin B, Jane D, Henley JM (2009) Dynamin-dependent membrane drift recruits AMPA receptors to dendritic spines. J Biol Chem 284:12491-12503.
27. Petrini EM, et al. (2009) Endocytic trafficking and recycling maintain a pool of mobile surface AMPA receptors required for synaptic potentiation. Neuron 63:92-105.
28. Morfini G, Szebenyi G, Elluru R, Ratner N, Brady ST (2002) Glycogen synthase kinase 3 phosphorylates kinesin light chains and negatively regulates kinesin-based motility. EMBO J 21:281-293.
29. Kim CH, Lisman JE (2001) A labile component of AMPA receptor-mediated synaptic transmission is dependent on microtubule motors, actin, and N-ethylmaleimide-sensitive factor. J Neurosci 21:4188-4194.
30. O'Donnell KC, Gould TD (2007) The behavioral actions of lithium in rodent models: Leads to develop novel therapeutics. Neurosci Biobehav Rev 31:932-962.
31. Gould TD, et al. (2008) Involvement of AMPA receptors in the antidepressant-like effects of lithium in the mouse tail suspension test and forced swim test. Neuropharmacology 54:577-587.
32. Carlezon WA, Jr, Thomas MJ (2009) Biological substrates of reward and aversion: A nucleus accumbens activity hypothesis. Neuropharmacology 56 (Suppl 1):122-132.
33. Grace AA, Floresco SB, Goto Y, Lodge DJ (2007) Regulation of firing of dopaminergic neurons and control of goal-directed behaviors. Trends Neurosci 30:220-227.
34. Lodge DJ, Grace AA (2008) Hippocampal dysfunction and disruption of dopamine system regulation in an animal model of schizophrenia. Neurotox Res 14:97-104.
35. Manji HK, et al. (2003) Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression. Biol Psychiatry 53: 707-742.
36. Du J, et al. (2004) Modulation of synaptic plasticity by antimanic agents: The role of AMPA glutamate receptor subunit 1 synaptic expression. J Neurosci 24:6578-6589.
37. Du J, et al. (2009) Dynamic regulation of mitochondrial function by glucocorticoids. Proc Natl Acad Sci USA 106:3543-3548.
38. Wang Y, Wu J, Rowan MJ, Anwyl R (1997) Conditions for the induction of long-term potentiation and long-term depression by conjunctive pairing in the dentate gyrus in vitro. J Neurophysiol 78:2569-2573.